{"name":"Centre Oscar Lambret","slug":"centre-oscar-lambret","ticker":"","exchange":"","domain":"centreoscarlambret.fr","description":"","hq":"Lille","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":12,"colorKey":"oncology","drugs":[{"name":"biological test","genericName":"biological test","slug":"biological-test","indication":"Other","status":"phase_1"},{"name":"Vincristine, Irinotecan, Temozolomide","genericName":"Vincristine, Irinotecan, Temozolomide","slug":"vincristine-irinotecan-temozolomide","indication":"Other","status":"phase_2"},{"name":"Cilengitide dose escalation","genericName":"Cilengitide dose escalation","slug":"cilengitide-dose-escalation","indication":"Other","status":"phase_1"},{"name":"Docetaxel: increase of the dose","genericName":"Docetaxel: increase of the dose","slug":"docetaxel-increase-of-the-dose","indication":"Other","status":"phase_2"},{"name":"Pharmacokinetic","genericName":"Pharmacokinetic","slug":"pharmacokinetic","indication":"Other","status":"phase_2"},{"name":"Biopsy","genericName":"Biopsy","slug":"biopsy","indication":"Other","status":"phase_2"},{"name":"Blood collection","genericName":"Blood collection","slug":"blood-collection","indication":"Other","status":"marketed"},{"name":"CPK dosage","genericName":"CPK dosage","slug":"cpk-dosage","indication":"Mucositis prevention in patients undergoing chemotherapy","status":"phase_2"},{"name":"Fluvastatine","genericName":"Fluvastatine","slug":"fluvastatine","indication":"Other","status":"phase_1"},{"name":"Paclitaxel dose escalation","genericName":"Paclitaxel dose escalation","slug":"paclitaxel-dose-escalation","indication":"Other","status":"phase_1"},{"name":"Pharmacogenetic","genericName":"Pharmacogenetic","slug":"pharmacogenetic","indication":"Other","status":"phase_1"},{"name":"Vincristine, Irinotecan","genericName":"Vincristine, Irinotecan","slug":"vincristine-irinotecan","indication":"Other","status":"phase_2"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"TEGAFUR URACIL - FOLINIC ACID","genericName":"TEGAFUR URACIL - FOLINIC ACID","slug":"tegafur-uracil-folinic-acid","indication":"Advanced colorectal cancer","status":"phase_3"},{"name":"CarboP-pacliT","genericName":"CarboP-pacliT","slug":"carbop-paclit","indication":"Non-small cell lung cancer","status":"phase_2"}]}],"pipeline":[{"name":"biological test","genericName":"biological test","slug":"biological-test","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Vincristine, Irinotecan, Temozolomide","genericName":"Vincristine, Irinotecan, Temozolomide","slug":"vincristine-irinotecan-temozolomide","phase":"phase_2","mechanism":"Combines microtubule disruption, topoisomerase I inhibition, and DNA alkylation to induce cancer cell death through multiple pathways.","indications":[],"catalyst":""},{"name":"Cilengitide dose escalation","genericName":"Cilengitide dose escalation","slug":"cilengitide-dose-escalation","phase":"phase_1","mechanism":"Cilengitide selectively inhibits αvβ3 and αvβ5 integrins, blocking tumor angiogenesis and cancer cell adhesion to the extracellular matrix.","indications":[],"catalyst":""},{"name":"Docetaxel: increase of the dose","genericName":"Docetaxel: increase of the dose","slug":"docetaxel-increase-of-the-dose","phase":"phase_2","mechanism":"Docetaxel binds to and stabilizes microtubules, preventing their depolymerization and thereby blocking cell division and inducing cancer cell death.","indications":[],"catalyst":""},{"name":"Pharmacokinetic","genericName":"Pharmacokinetic","slug":"pharmacokinetic","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"TEGAFUR URACIL - FOLINIC ACID","genericName":"TEGAFUR URACIL - FOLINIC ACID","slug":"tegafur-uracil-folinic-acid","phase":"phase_3","mechanism":"Tegafur uracil combined with folinic acid enhances the cytotoxic effects of 5-fluorouracil by increasing its intracellular concentration and prolonging its action.","indications":["Advanced colorectal cancer","Gastric cancer"],"catalyst":""},{"name":"Biopsy","genericName":"Biopsy","slug":"biopsy","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Blood collection","genericName":"Blood collection","slug":"blood-collection","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"CPK dosage","genericName":"CPK dosage","slug":"cpk-dosage","phase":"phase_2","mechanism":"CPK is a recombinant human keratinocyte growth factor used to stimulate epithelial regeneration.","indications":["Mucositis prevention in patients undergoing chemotherapy"],"catalyst":""},{"name":"CarboP-pacliT","genericName":"CarboP-pacliT","slug":"carbop-paclit","phase":"phase_2","mechanism":"CarboP-pacliT is a chemotherapy medication that works by interfering with DNA replication in cancer cells.","indications":["Non-small cell lung cancer"],"catalyst":""},{"name":"Fluvastatine","genericName":"Fluvastatine","slug":"fluvastatine","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Paclitaxel dose escalation","genericName":"Paclitaxel dose escalation","slug":"paclitaxel-dose-escalation","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Pharmacogenetic","genericName":"Pharmacogenetic","slug":"pharmacogenetic","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Vincristine, Irinotecan","genericName":"Vincristine, Irinotecan","slug":"vincristine-irinotecan","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNaG0zdVNIYUw0SGhua2FaR25HbHoyWXlrLTVYRjB6UTNYbk5KTF9vRXBkT1dYVVpMMDBsa0Z5QXZtOTU5N0VVQTlLTGFBNnRzdUNIdU5Bd3BUSHhqbi1aVW1hcy10aExlOEtsSDIzNWNVb3J1NGpucndORHUwQVQ5WDZTa1NobjdoQWZfa282QXFHd0pmOUZlOA?oc=5","date":"2013-06-07","type":"pipeline","source":"Imaging Technology News","summary":"First Patient Treated Worldwide with Accuray's New TomoHDA System - Imaging Technology News","headline":"First Patient Treated Worldwide with Accuray's New TomoHDA System","sentiment":"neutral"}],"patents":[],"drugCount":14,"phaseCounts":{"phase_1":5,"phase_2":7,"phase_3":1,"marketed":1},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}